Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
8 hedge funds and large institutions have $727K invested in Peak Bio, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$84.5K |
| 2 |
LA
Linden Advisors
New York
|
+$68.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$59.4K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$56.3K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$42.2K |
Top Sellers
PKBOW Hedge Fund Activity: Q1 2021 in Review
8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q1 2021, worth a combined $727K.
Buyers outnumbered sellers: 8 funds opened new PKBOW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $84.5K.
- 8 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $727K of Peak Bio, Inc. Warrant stock for Q1 2021.
- 8 funds opened new Peak Bio, Inc. Warrant positions in Q1 2021 and 0 closed out, a net change of +8 holders.
- The largest Peak Bio, Inc. Warrant buyer in Q1 2021 was Periscope Capital, an estimated $84.5K added.
Based on aggregated 13F filings for Q1 2021.